Master the Price Analysis Tab through video tutorial, audio deep dive, comprehensive overview, and interactive knowledge testing
This comprehensive tutorial teaches you how to use the Price Analysis Tab in the Finmagine Financial Chart Builder to decode stock valuations on Screener.in. You will learn a systematic 3-point framework that transforms the most expensive question in investing—"Is this stock actually worth buying right now?"—into a data-driven decision.
Follow along with this deep-dive video breaking down the Price Analysis 3-point framework with real stock examples.
Video Title: Stop Guessing Stock Prices | Decode Value with FinMagine Price Analysis (3-Point Framework)
Complete video breakdown with real company examples: Bajaj Finance, Titan, Coforge, Tata Elxsi, and more
Prefer to listen? This in-depth audio discussion covers the entire Price Analysis framework, case studies, and investment strategies in a conversational format.
Duration: Full deep dive | Format: Conversational discussion
Deep dive audio exploring the Price/Profit Growth Ratio, cyclical analysis strategies, risk metrics, and the falling knife trap
Click any flashcard to reveal the answer. Use the search box to find specific topics.
You know the feeling. Your finger is hovering over the buy button on your brokerage app. You're staring at a ticker symbol—maybe it's a massive compounder like Bajaj Finance, or a momentum darling like TVS Motor—and the stock price is just sitting there, blinking at you. And that nagging voice in your head is asking what has to be the most expensive question in the history of finance: Is this thing actually worth it?
Usually, we answer that question with terrible shortcuts. The chart's going up and to the right, so it must be a winner. Or it dropped 10%, so it must be on sale—time to buy the dip. That's about as scientific as picking a racehorse because you like the colour of the jockey's silks.
The problem is a massive information gap between seeing a price and understanding the context of that price. Standard tools like Google Finance or your broker's app are fantastic at showing you the price. But they are terrible at telling you whether that price is justified by fundamentals, whether the stock usually crashes at this time of year, or how much pain you might suffer if you buy at exactly the wrong moment.
That is the gap the Price Analysis Tab in the Finmagine Financial Chart Builder is designed to bridge. It takes the raw data already on your Screener.in page and synthesises it into three actionable lenses—all running client-side in your browser with complete privacy.
Today, we are doing a complete deep dive into this tool. We'll break it down into a practical 3-point framework that answers the only three questions that matter before you buy any stock:
The Price Analysis Tab is built on a simple but powerful philosophy. While Screener.in provides raw tables of financial data, this tab synthesises that data into three distinct analytical lenses, each answering a different dimension of the investment decision.
Question: Is the price justified by profit growth?
This is the Price vs Fundamentals panel. It compares how fast the stock price is growing against how fast the company's profits are growing. If price is running ahead of profits, you might be paying too much. If profits are outpacing price, you may have found a bargain.
Question: Is there a predictable seasonal pattern?
This is the Cyclical Analysis panel. It groups historical quarterly profits by month and identifies repeatable seasonal patterns. Knowing which quarters are typically strong or weak lets you time entries and—just as importantly—avoid panic selling during predictable dips.
Question: What is the risk of entry at this level?
This is the Risk Metrics panel. It shows where the current price sits within the 52-week range, calculates the maximum drawdown, and helps you understand how volatile the stock is. This is your "pain threshold" gauge.
The Price Analysis Tab is available only on Screener.in because it requires data that Google Finance does not provide: Stock Price CAGR, Compounded Sales and Profit Growth rates, detailed quarterly profits, and 52-week High/Low prices.
screener.in/company/BAJFINANCE/consolidated/)The tab opens into a clean two-column dashboard. On the left is the heavy lifter—the Price vs Fundamentals panel with the CAGR Comparison Table below it. On the right are two stacked panels: Cyclical Analysis on top and Risk Metrics on the bottom. The current stock price with daily change is displayed prominently in the header.
This is the heart of the Price Analysis Tab. It answers the million-rupee question: Is the stock price justified by the company's fundamental growth?
The core metric is surprisingly simple but incredibly powerful. It takes the Stock Price CAGR (Compound Annual Growth Rate) and divides it by the Profit CAGR, primarily using a 5-year timeframe to capture full business cycles.
Think of it like walking a dog. The company's profit growth is the owner walking steadily forward—that is reality, the solid ground. The stock price is the dog on the leash. Sometimes the dog runs way ahead (hype, overvaluation). Sometimes it lags behind, sniffing a bush (fear, undervaluation). But eventually, the dog has to come back to the owner. This ratio measures how far the leash is stretched.
Based on the ratio, the tool assigns one of three status badges:
| Badge | Ratio | Meaning | Investor Action |
|---|---|---|---|
| CATCHING UP | < 0.7x | Price growth lagging behind profit growth | Research for potential undervaluation |
| FAIRLY VALUED | 0.7x – 1.3x | Price and profits growing at similar rates | Neutral – focus on future expectations |
| RUNNING AHEAD | > 1.3x | Price growing 30%+ faster than profits | Caution – verify growth sustainability |
Let's make this concrete with two real-world examples that illustrate the opposite ends of the spectrum.
Bajaj Finance's profits have been growing at an extraordinary 26% annually over the last five years. The business is effectively doubling in size every three years. But the stock price? It has only grown at 12% annually over the same period.
The ratio: 12 ÷ 26 = 0.46x. The owner (profits) is sprinting at 26 mph, but the dog (price) is jogging at 12 mph. The tool flags this as CATCHING UP—fundamentals are outpacing the hype. The thesis is that eventually that gap has to close, and when it does, you get significant price appreciation.
Now look at Coforge—the inverse of Bajaj Finance. The stock price has been zooming at a 24% CAGR. It looks like a superstar on any chart. But profits? They've only been growing at 13%.
The ratio: 24 ÷ 13 = 1.85x. Investors are paying a massive premium for future growth that hasn't materialised yet. They're pricing in years of perfect execution. The tool flags this as RUNNING AHEAD.
Below the badges, you'll find the CAGR Comparison Table—the truth-teller of the dashboard. It shows growth rates across multiple timeframes so you can see the full picture:
| Period | What It Tells You |
|---|---|
| 10Y | Long-term structural growth (if available) |
| 5Y | Primary comparison period – captures full business cycles |
| 3Y | Medium-term trend – useful for newer companies |
| 1Y / TTM | Recent momentum – critical for detecting acceleration or collapse |
This is where the tutorial can genuinely save you money. A green CATCHING UP badge is not always a buy signal. Sometimes it's a trap that can cost you dearly.
A falling knife is a stock that looks cheap because it used to be great, but is crashing because the business is dying right now. The five-year average still looks strong because it's propped up by four good years. But in year five, everything collapsed.
The tool sees the price dropping hard, compares it to the still-strong five-year profit average, and assigns a green "Catching Up" badge. On the surface, it looks like a hidden gem. In reality, you're about to catch a falling knife.
The fix is one simple comparison in the CAGR table at the bottom of the panel:
On the surface, Tata Elxsi looks like a dream for value investors. Five-year profit growth is a spectacular 25%. Price growth is only 13%. The ratio is 0.52x. Green badge, catching up, looks like a steal.
But then you scroll down to the CAGR table and check the 1Y/TTM profit growth: -22%. The business has shrunk by more than a fifth in the last year. The stock isn't lagging because the market is ignoring a gem. It's crashing because earnings have collapsed. This is a textbook falling knife.
Abbott India also has a "Catching Up" badge and is trading near its lows. Looks similar on the surface. But the CAGR table tells a completely different story: 5Y profit growth is 19%, and 1Y profit growth is 17%. The profit engine is still humming at nearly the exact same speed. The price drop is likely just market sentiment, not business deterioration.
| Signal | Value Opportunity (Buy) | Falling Knife (Avoid) |
|---|---|---|
| Valuation Badge | CATCHING UP (Green) | Could be Catching Up too (deceptive) |
| 1Y vs 5Y Profit | 1Y stable or accelerating | 1Y negative or collapsing |
| Max Drawdown | Moderate (<30%) | High (>40-50%) |
| Reason for Drop | External (market sentiment) | Internal (broken fundamentals) |
Knowing a stock is worth buying is only half the battle. The second question is: When? There's almost nothing worse than buying a great company and watching it do nothing—or drop—for three months because you bought at the wrong time of year.
The Cyclical Analysis panel quantifies something that is usually just gossip or anecdotal evidence. You hear people say "auto stocks always do well around Diwali" or "infrastructure companies have a strong March quarter." But is that actually true? This panel runs the actual numbers.
That 30% threshold is an important filter. If the difference from best to worst is only 5%, that's random fluctuation, not a pattern. But if one quarter is consistently 30%+ more profitable than another, that's a structural seasonal pattern you can exploit.
The tool ranks each quarter from #1 (strongest) to #4 (weakest), with colour coding: dark green for #1, light green for #2, yellow for #3, and red for #4. This ranking is your timing compass.
GRSE is in the infrastructure and defence shipbuilding space—a sector heavily driven by government spending and billing cycles.
If you own GRSE and the June quarter results look terrible, the tool lets you stay calm. June is always the worst quarter for this company. It's not a business failure, it's a calendar feature. You don't panic sell at the bottom of a predictable cycle.
If March is the peak when hype is highest, you probably don't want to buy in late February. Instead, look at GRSE during the May/June weakness when sentiment is low and position yourself for the next upcycle. You're using data to buy fear and sell greed.
| Industry | Typical Peak Quarter | Driver |
|---|---|---|
| Infrastructure & Construction | Q4 (March) | Government budget spending and fiscal year-end billing |
| Retail & FMCG | Q3 (Oct-Dec) | Diwali, festive season, and holiday shopping |
| Automotive | Q2 (Sep) & Q4 (Mar) | Festive demand stocking and year-end sales incentives |
| Agriculture | Seasonal | Harvest cycles and monsoon patterns |
| Paints | Q1 (June) | Pre-monsoon exterior painting season |
The final lens answers the scariest question: How much pain might I suffer if I'm wrong? This panel is built around two key concepts: the 52-week price range and the Max Drawdown.
A simple horizontal bar shows exactly where the current price sits between its yearly low and yearly high. The tool classifies this position into three zones:
| Zone | Condition | Psychology | Risk Profile |
|---|---|---|---|
| Near 52W High (Yellow) | Within 10% of yearly peak | Momentum / FOMO zone | "Consider if valuation is justified" |
| Mid Range (Blue) | Between the extremes | Neutral / Safe accumulation | Balanced risk-reward |
| Near 52W Low (Green) | Within 20% of yearly bottom | Value or Falling Knife? | "Could be opportunity or trap" |
Max Drawdown answers one brutal question: If I had the worst possible luck and bought at the absolute highest price last year, how much money would I have lost when it hit the absolute lowest?
| Drawdown | Risk Level | Interpretation | Strategy |
|---|---|---|---|
| < 20% | Low | Highly stable, shallow corrections | Safe for momentum entries / breakouts |
| 20% – 40% | Moderate | Normal market volatility | Standard entry rules apply |
| 40% – 60% | High | Significant volatility, deep corrections | Avoid buying at highs; wait for pullbacks |
| > 60% | Extreme | Extreme instability or fundamental issues | Requires strict stop-losses or avoidance |
TVS Motor presents the classic "Triple Threat" of risk factors hitting simultaneously:
You're buying at the absolute top of the price range, the price is already running far ahead of fundamentals, and the stock has a documented history of crashing by nearly 44%. That is a genuinely terrifying combination. You're walking a tightrope without a safety net.
Contrast this with Abbott India: trading Near 52W Low, with a much more modest Max Drawdown of 28.6%. Abbott rarely falls more than 30% from its peak, so if you find it near its low, you're likely standing on solid concrete, not quicksand. The downside from there is historically limited.
Now we combine all three lenses into concrete, actionable investment plays. Here is how the dashboard elements work together to produce clear verdicts.
The checklist for the ideal value setup:
Example: Bajaj Finance checks every single box. It's Catching Up (ratio 0.46x), the one-year fundamentals are stable, it's sitting in the Mid Range (22.6% above low, 10.8% below high), and the Max Drawdown is a manageable 27.2%. For a long-term value investor, that's a textbook setup.
The checklist for the dangerous setup (the Triple Threat):
Example: TVS Motor checks all the bad boxes. It's a perfect storm of high valuation, peak pricing, and high volatility. If you own it, consider taking profits. If you don't own it, stay away until valuation and price cool down.
| Entry Zone | Valuation Status | Max Drawdown | Verdict |
|---|---|---|---|
| Near 52W Low | CATCHING UP | < 30% | Strong Buy Consideration |
| Mid Range | CATCHING UP | < 40% | Safe Accumulation |
| Near 52W Low | Any | > 50% | Risky (Potential Falling Knife) |
| Near 52W High | RUNNING AHEAD | > 40% | Dangerous Entry / Avoid |
| Near 52W High | FAIRLY VALUED | < 20% | Safer Momentum Play |
Keep this quick-reference table handy whenever you're using the Price Analysis tab.
| Metric | Reading | Action |
|---|---|---|
| Price/Profit Ratio | < 0.7x (Green) | Research for Value |
| Price/Profit Ratio | > 1.3x (Red) | Exercise Caution / Take Profit |
| Cyclicality | Rank #1 (Mar/Sep/etc) | Sell into strength / Hold |
| Cyclicality | Rank #4 | Buy into weakness (if fundamentals solid) |
| Max Drawdown | > 40% | NEVER buy at 52W High |
| 1Y Profit vs 5Y | Negative Divergence | Avoid (Falling Knife) |
All calculations occur locally in your browser. No financial data is sent to external servers. In an era where every app wants to harvest your data, this is a refreshing commitment to privacy.
The tool primarily uses 5-Year CAGR for valuation comparison. If 5Y data is unavailable (e.g., recently listed companies), it automatically falls back to 3-Year CAGR. The "Long-Term Insight" section notes which timeframe was used.
Cause: Company is recently listed (<3 years) or lacks Stock Price CAGR data on Screener.in.
Solution: Focus on Risk Metrics and Cyclical Analysis (these may still work). Use the Charts tab for visual comparison.
Cause: Less than 4 quarters of profit data available.
Solution: Check if the company is newly listed. Try consolidated vs standalone view.
Cause: 52-week High/Low data not available on the page.
Solution: Ensure the company is actively traded. Refresh the page.
Verification: Scroll to Screener.in's growth boxes and compare. If there's a mismatch, refresh the page and reopen the extension. If Screener.in shows only "%" without a number, the extension correctly displays "-".
| Data Point | Source on Screener.in |
|---|---|
| Current Price | Company header |
| 52W High / Low | Top ratios section |
| Stock Price CAGR | "Stock Price CAGR" growth table |
| Profit CAGR | "Compounded Profit Growth" table |
| Sales CAGR | "Compounded Sales Growth" table |
| Quarterly Profits | Quarterly P&L "Net Profit" row |
The Price Analysis Tab contextualises the noise. It transforms the most expensive question in investing—"Is this stock worth buying right now?"—into three simple, data-driven checks:
What You've Learned:
We often look at big price drops as failures, as something to fear. But what if you knew, based on data, that a great company always drops in June? Or that it always has a 40% crash from its peak before rallying to new highs? Would you still be scared of that drop? Or would you be waiting for it, patiently, with your checkbook ready?
That's the difference this tool makes. It transforms market anxiety into market strategy.
Price analysis is based on historical data extracted from public sources and should not be considered investment advice. Past performance is not indicative of future results. The "Catching Up" and "Running Ahead" badges are mathematical ratios, not buy/sell recommendations. Users should conduct their own due diligence.
Discover all Chart Builder resources — tutorials for the Charts Tab, Quick Analysis, Calculated Ratios, Google Finance integration, and more.
Visit Chart Builder Hub →